Overview

A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a Abdominoplasty.
Phase:
PHASE3
Details
Lead Sponsor:
Tris Pharma, Inc.
Treatments:
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine